AAAAAA
Results: 376-400/568
Authors:
BOLOGNESI A
TAZZARI PL
LEGNAME G
OLIVIERI F
MODENA D
CONTE R
STIRPE F
Citation: A. Bolognesi et al., ANTI-CD30 IMMUNOTOXINS WITH NATIVE AND RECOMBINANT DIANTHIN-30, Cancer immunology and immunotherapy, 40(2), 1995, pp. 109-114
Authors:
OTTO F
MACKENSEN A
MERTELSMANN R
ENGELHARDT R
Citation: F. Otto et al., COMPLETE RESPONSE OF METASTATIC RENAL-CELL CARCINOMA TO LOW-DOSE INTERFERON-GAMMA TREATMENT, Cancer immunology and immunotherapy, 40(2), 1995, pp. 115-118
Authors:
JACKSON AM
ALEXANDROV AB
PRESCOTT S
JAMES K
Citation: Am. Jackson et al., PRODUCTION OF URINARY TUMOR NECROSIS FACTORS AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN BLADDER-CANCER PATIENTS AFTER BACILLUS-CALMETTE-GUERIN IMMUNOTHERAPY, Cancer immunology and immunotherapy, 40(2), 1995, pp. 119-124
Authors:
BALEMANS LTM
STEERENBERG PA
KREMER BHA
KOPPENHAGEN FJ
DEMULDER PHM
DENOTTER W
Citation: Ltm. Balemans et al., SPECIFIC TUMOR MEMORY INDUCED BY POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 REQUIRES BOTH HELPER AND CYTOTOXIC T-CELLS, Cancer immunology and immunotherapy, 40(2), 1995, pp. 125-131
Authors:
CROCE MV
PRICE MR
SEGALEIRAS A
Citation: Mv. Croce et al., EXPRESSION OF MONOCLONAL-ANTIBODY-DEFINED ANTIGENS IN FRACTIONS-ISOLATED FROM HUMAN BREAST CARCINOMAS AND PATIENTS SERUM, Cancer immunology and immunotherapy, 40(2), 1995, pp. 132-137
Authors:
DADMARZ R
SGAGIAS MK
ROSENBERG SA
SCHWARTZENTRUBER DJ
Citation: R. Dadmarz et al., CD4(-LYMPHOCYTES INFILTRATING HUMAN BREAST-CANCER RECOGNIZE AUTOLOGOUS TUMOR IN AN MHC-CLASS-II RESTRICTED FASHION() T), Cancer immunology and immunotherapy, 40(1), 1995, pp. 1-9
Authors:
JIMBO T
AKIMOTO T
TOHGO A
Citation: T. Jimbo et al., EFFECT OF COMBINED ADMINISTRATION OF A SYNTHETIC LOW TOXICITY LIPID-ADERIVATIVE, DT-5461A, AND INDOMETHACIN IN VARIOUS EXPERIMENTAL TUMOR-MODELS OF COLON-26 CARCINOMA IN MICE, Cancer immunology and immunotherapy, 40(1), 1995, pp. 10-16
Authors:
IWANUMA Y
KATO K
YAGITA H
OKUMURA K
Citation: Y. Iwanuma et al., INDUCTION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES AND NATURAL-KILLER-CELLS BY TUMOR-CELLS TRANSFECTED WITH THE INTERLEUKIN-2 GENE, Cancer immunology and immunotherapy, 40(1), 1995, pp. 17-23
Authors:
BUIST MR
KENEMANS P
VANKAMP GJ
HAISMA HJ
Citation: Mr. Buist et al., MINOR HUMAN-ANTIBODY RESPONSE TO A MOUSE AND CHIMERIC MONOCLONAL-ANTIBODY AFTER A SINGLE IV INFUSION IN OVARIAN-CARCINOMA PATIENTS - A COMPARISON OF 5 ASSAYS, Cancer immunology and immunotherapy, 40(1), 1995, pp. 24-30
Authors:
BARBUTO JAM
GRIMES WJ
HERSH EM
Citation: Jam. Barbuto et al., ANTIBODIES TO TUMOR-NECROSIS-FACTOR - A COMPONENT OF B-CELL IMMUNE-RESPONSES WITH A ROLE IN TUMOR HOST INTERACTION, Cancer immunology and immunotherapy, 40(1), 1995, pp. 31-36
Authors:
VLASVELD LT
HEKMAN A
VYTHDREESE FA
MELIEF CJM
SEIN JJ
VOORDOUW AC
DELLEMIJN TAM
RANKIN EM
Citation: Lt. Vlasveld et al., TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA WITH CONTINUOUS-INFUSIONOF LOW-DOSE RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH THE B-CELL-SPECIFIC MONOCLONAL-ANTIBODY CLB-CD19, Cancer immunology and immunotherapy, 40(1), 1995, pp. 37-47
Authors:
STOCK R
NAOR D
Citation: R. Stock et D. Naor, INDUCTION OF AN AUTOIMMUNE-RESPONSE AGAINST SYNGENEIC LYMPHOMA-CELLS BY IMMUNOGENIC 64-KDA PROTEIN ISOLATED FROM NORMAL BLAST CELLS OF BALBC MICE/, Cancer immunology and immunotherapy, 40(1), 1995, pp. 48-56
Authors:
RISIN D
UMEZU Y
BALCH CM
KLEINERMAN ES
PIZZINI RP
PELLIS NR
Citation: D. Risin et al., IMPAIRMENT OF LYMPHOCYTE LOCOMOTION IN THE TUMOR MICROENVIRONMENT ANDTHE EFFECT OF SYSTEMIC IMMUNOTHERAPY WITH LIPOSOME-ENCAPSULATED MURAMYL-TRIPEPTIDE-PHOSPHATIDYLETHANOLAMINE, Cancer immunology and immunotherapy, 40(1), 1995, pp. 57-64
Authors:
VAILLIER D
DACULSI R
GUALDE N
Citation: D. Vaillier et al., HETEROGENEITY OF MURINE ADHERENT INTERLEUKIN-2-ACTIVATED KILLER-CELLS- DIFFERENTIAL EFFECT OF PROSTAGLANDIN E(2) AND FORSKOLIN, Cancer immunology and immunotherapy, 40(1), 1995, pp. 65-71
Authors:
BIELEFELDTOHMANN H
FITZPATRICK DR
MARZO AL
JARNICKI AG
HIMBECK RP
DAVIS MR
MANNING LS
ROBINSON BWS
Citation: H. Bielefeldtohmann et al., PATHOBIOLOGY AND IMMUNOBIOLOGY OF MALIGNANT MESOTHELIOMA - CHARACTERIZATION OF TUMOR-INFILTRATING LEUKOCYTES AND CYTOKINE PRODUCTION IN A MURINE MODEL, Cancer immunology and immunotherapy, 39(6), 1994, pp. 347-359
Authors:
SAHASRABUDHE DM
DUSEL JC
Citation: Dm. Sahasrabudhe et Jc. Dusel, EFFECT OF MURINE INTERFERON-ALPHA BETA ON TUMOR-INDUCED SUPPRESSOR FUNCTION/, Cancer immunology and immunotherapy, 39(6), 1994, pp. 360-366
Authors:
MCGRAW KJ
ROSENBLUM MG
CHEUNG L
SCHEINBERG DA
Citation: Kj. Mcgraw et al., CHARACTERIZATION OF MURINE AND HUMANIZED ANTI-CD33, GELONIN IMMUNOTOXINS REACTIVE AGAINST MYELOID LEUKEMIAS, Cancer immunology and immunotherapy, 39(6), 1994, pp. 367-374
Authors:
WESTERA G
RULICKE T
SMITH A
DUEWELL S
Citation: G. Westera et al., DIFFERENCES IN BIODISTRIBUTION OF THE ANTI-(CARCINOEMBRYONIC ANTIGEN)MURINE MONOCLONAL-ANTIBODY-CE-25, ITS F(AB')(2)-FRAGMENT AND ITS INTACT MAINLY HUMAN CHIMERIC FORM CE-4-8-23 - DEPENDENCE ON TUMOR SIZE ANDAMOUNT OF ANTIBODY INJECTED, Cancer immunology and immunotherapy, 39(6), 1994, pp. 375-382
Authors:
HALD J
RASMUSSEN N
CLAESSON MH
Citation: J. Hald et al., IN-VIVO INFILTRATION OF MONONUCLEAR-CELLS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK CORRELATES WITH THE ABILITY TO EXPAND TUMOR-INFILTRATING T-CELLS IN-VITRO AND WITH THE EXPRESSION OF MHC CLASS-I ANTIGENS ON TUMOR-CELLS, Cancer immunology and immunotherapy, 39(6), 1994, pp. 383-390
Authors:
HAAGEN IA
DELAU WBM
BAST BJEG
GEERARS AJG
CLARK MR
DEGAST BC
Citation: Ia. Haagen et al., UNPRIMED CD4-CELLS CAN BE RAPIDLY ACTIVATED BY A CD3-X-CD19 BISPECIFIC ANTIBODY TO PROLIFERATE AND BECOME CYTOTOXIC( AND CD8+ T), Cancer immunology and immunotherapy, 39(6), 1994, pp. 391-396
Authors:
ROSENBLUM MG
LEVIN B
ROH M
HOHN D
MCCABE R
THOMPSON L
CHEUNG L
MURRAY JL
Citation: Mg. Rosenblum et al., CLINICAL-PHARMACOLOGY AND TISSUE DISPOSITION STUDIES OF I-131-LABELEDANTICOLORECTAL CARCINOMA HUMAN MONOCLONAL-ANTIBODY LICO-16.88, Cancer immunology and immunotherapy, 39(6), 1994, pp. 397-400
Authors:
MCAVENEY KM
GOMELLA LG
LATTIME EC
Citation: Km. Mcaveney et al., INDUCTION OF TH1-ASSOCIATED AND TH2-ASSOCIATED CYTOKINE MESSENGER-RNAIN MOUSE BLADDER FOLLOWING INTRAVESICAL GROWTH OF THE MURINE BLADDER TUMOR-MB49 AND TUMOR-BCG IMMUNOTHERAPY, Cancer immunology and immunotherapy, 39(6), 1994, pp. 401-406
Authors:
YASUMURA S
AMOSCATO A
HIRABAYASHI H
LIN WC
WHITESIDE TL
Citation: S. Yasumura et al., PROLIFERATION OF HEMATOPOIETIC-CELL LINES INDUCED BY A SOLUBLE FACTORDERIVED FROM HUMAN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK, Cancer immunology and immunotherapy, 39(6), 1994, pp. 407-415
Authors:
HELLSTRAND K
NAREDI P
LINDNER P
LUNDHOLM K
RUDENSTAM CM
HERMODSSON S
ASZTELY M
HAFSTROM L
Citation: K. Hellstrand et al., HISTAMINE IN IMMUNOTHERAPY OF ADVANCED MELANOMA - A PILOT-STUDY, Cancer immunology and immunotherapy, 39(6), 1994, pp. 416-419
Authors:
LIU SQ
SHIBA R
KIM BS
SAIJO K
OHNO T
Citation: Sq. Liu et al., LONG-TERM SERUM PLASMA-FREE CULTURE OF HUMAN CYTOTOXIC T-LYMPHOCYTES INDUCED FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS/, Cancer immunology and immunotherapy, 39(5), 1994, pp. 279-285